Morbilliform erythema-multiforme-like eruption from desoxymethasone.
Stingeni
L
L
Department of Medical and Surgical Specialities, University of Perugia, Italy.
Hansel
K
K
Lisi
P
P
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003899:Desoximetasone / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D004655:Emulsions; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010328:Patch Tests; D012008:Recurrence; D014689:Venous Insufficiency / Q000150:complications / Q000188:drug therapy; D015034:Zinc Oxide / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004655:Emulsions; D005938:Glucocorticoids; D009824:Ointments; D003899:Desoximetasone; D015034:Zinc Oxide